These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 23725755

  • 1. STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells.
    Kiper HD, Tezcanli Kaymaz B, Gokbulut AA, Selvi N, Avci CB, Kosova B, Iskender G, Yandim MK, Gunduz C, Sahin F, Baran Y, Saydam G.
    Biomed Pharmacother; 2013 Jul; 67(6):527-32. PubMed ID: 23725755
    [Abstract] [Full Text] [Related]

  • 2. Investigating the Role of JAK/STAT Pathway on Dasatinib-Induced Apoptosis for CML Cell Model K562.
    Dalgıç CT, Kaymaz BT, Özkan MC, Dalmızrak A, Şahin F, Saydam G.
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S161-6. PubMed ID: 26297271
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ, Yu YZ, Fang YM, Liang Y, Lü QH, Xu RZ.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 20; 85(27):1903-6. PubMed ID: 16255985
    [Abstract] [Full Text] [Related]

  • 5. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
    Chen Y, Wang T, Du J, Li Y, Wang X, Zhou Y, Yu X, Fan W, Zhu Q, Tong X, Wang Y.
    Cell Physiol Biochem; 2018 Jul 20; 47(3):981-993. PubMed ID: 29843123
    [Abstract] [Full Text] [Related]

  • 6. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells.
    Blasius R, Reuter S, Henry E, Dicato M, Diederich M.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1547-54. PubMed ID: 16959222
    [Abstract] [Full Text] [Related]

  • 7. Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs/Bcl-XL signal pathway.
    Zhang G, Fu Y.
    Ann Hematol; 2006 Jul 30; 85(7):443-9. PubMed ID: 16572323
    [Abstract] [Full Text] [Related]

  • 8. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Exp Cell Res; 2009 Jul 01; 315(11):1809-18. PubMed ID: 19268463
    [Abstract] [Full Text] [Related]

  • 9. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.
    Kaymaz BT, Selvi N, Gündüz C, Aktan C, Dalmızrak A, Saydam G, Kosova B.
    Ann Hematol; 2013 Jan 01; 92(2):151-62. PubMed ID: 23053176
    [Abstract] [Full Text] [Related]

  • 10. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.
    Wei W, Huang H, Zhao S, Liu W, Liu CX, Chen L, Li JM, Wu YL, Yan H.
    Apoptosis; 2013 Sep 01; 18(9):1060-70. PubMed ID: 23613107
    [Abstract] [Full Text] [Related]

  • 11. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.
    Kindler T, Breitenbuecher F, Kasper S, Stevens T, Carius B, Gschaidmeier H, Huber C, Fischer T.
    Leukemia; 2003 Jun 01; 17(6):999-1009. PubMed ID: 12764361
    [Abstract] [Full Text] [Related]

  • 12. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
    Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ.
    Clin Cancer Res; 2004 Oct 01; 10(19):6661-8. PubMed ID: 15475456
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells.
    Zhu X, Li Y, Luo X, Fei J.
    Cell Signal; 2012 Jun 01; 24(6):1134-40. PubMed ID: 22330069
    [Abstract] [Full Text] [Related]

  • 15. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 16. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation.
    Chandramohan Reddy T, Bharat Reddy D, Aparna A, Arunasree KM, Gupta G, Achari C, Reddy GV, Lakshmipathi V, Subramanyam A, Reddanna P.
    Toxicol In Vitro; 2012 Apr 01; 26(3):396-405. PubMed ID: 22245431
    [Abstract] [Full Text] [Related]

  • 17. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM, Liu JC.
    J Cell Physiol; 2009 Mar 01; 218(3):568-74. PubMed ID: 19006173
    [Abstract] [Full Text] [Related]

  • 18. Apoptotic effect of As2S2 on K562 cells and its mechanism.
    Li JE, Wu WL, Wang ZY, Sun GL.
    Acta Pharmacol Sin; 2002 Nov 01; 23(11):991-6. PubMed ID: 12421474
    [Abstract] [Full Text] [Related]

  • 19. [Different sensitivity of two chronic myeloid leukemia cell lines to interferon-alpha].
    Li XM, Chen HC, Liu XF, Wu YH, Cao YF.
    Ai Zheng; 2003 Oct 01; 22(10):1047-52. PubMed ID: 14558948
    [Abstract] [Full Text] [Related]

  • 20. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Liao HF, Su YC, Zheng ZY, Jhih Cai C, Hou MH, Chao KS, Chen YJ.
    Biomed Pharmacother; 2012 Jul 01; 66(5):378-83. PubMed ID: 22397755
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.